Taking the Pulse® Asia Gives Insight to How Physicians Use Technology

Manhattan ResearchManhattan Research, a global healthcare and pharmaceutical market research company, has announced the launch of Taking the Pulse® Asia, its latest physician market research and advisory service. The service is part of Manhattan Research's overall insight into global digital trends and focuses on physicians across Japan, China, South Korea, Taiwan, and Australia.

Healthcare and pharmaceutical marketers and other industry stakeholders will use Taking the Pulse® Asia to examine strategic technology, media, channel, and promotional mix trends as well as to benchmark their performance against industry competitors. Subscribers also have access to the Manhattan Research global analyst team for insights on using the market data to shape better-informed marketing and sales strategies.

Taking the Pulse® Asia covers topics such as:

  • Interest in Web 2.0 technologies for health and pharmaceutical information
  • Overall media consumption (traditional vs. new media)
  • Use and impact of sales representatives for clinical and pharmaceutical information
  • Internet access, frequency, types, and activities online
  • Mobile technology adoption, including PDAs/smartphones, MP3/iPods, and SMS messaging
  • Advanced online activities such as online video, blogs, podcasting, and wikis
  • Search engine reliance and frequency
  • Interest in health email newsletters, chat groups, and disease management tools

"This comprehensive review of both established and emerging markets in Asia provides our clients in the life sciences industry with a robust analysis of digital opportunities and the impact on sales and marketing today and in the near future," states Mark Bard, president of Manhattan Research. "After years of successfully providing strategic insight into the rapidly evolving markets in the United States and Europe, we are proud to offer this view of Japan, China, South Korea, Taiwan, and Australia to our clients. They demanded a global view of digital and global benchmarking metrics and we have delivered."

Mark Bard will be sharing physician digital marketing insights from Taking the Pulse® Asia and global trends at the upcoming eyeforpharma Pharma Marketing Excellence Japan conference, taking place February 3-4, 2009 at the Sheraton Miyako Hotel in Tokyo.

For additional Taking the Pulse® Asia product and subscription information, please visit http://www.manhattanresearch.com/products/physician/asia.aspx

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm. We conduct annual research studies covering eHealth trends among physicians and consumers in the United States, Europe, and Asia. For information, visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...